PHARMARESEARCH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 135,800 KRW | +0.67% |
|
+6.43% | +24.02% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 304B 223M | Sales 2025 * | 346B 253M | Capitalization | 1,390B 1.02B |
|---|---|---|---|---|---|
| Net income 2024 * | 100B 73.1M | Net income 2025 * | 117B 85.53M | EV / Sales 2024 * | 4.01 x |
| Net cash position 2024 * | 169B 124M | Net cash position 2025 * | 294B 215M | EV / Sales 2025 * | 3.17 x |
| P/E ratio 2024 * |
14
x | P/E ratio 2025 * |
12
x | Employees | 354 |
| Yield 2024 * |
0.62% | Yield 2025 * |
0.67% | Free-Float | 60.05% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.67% | ||
| 1 week | +6.43% | ||
| Current month | +6.43% | ||
| 1 month | +22.67% | ||
| 3 months | +31.46% | ||
| 6 months | +13.07% | ||
| Current year | +24.02% |
1 week
125 900.00
143 000.00
1 month
107 700.00143 000.00
Current year
86 800.00143 000.00
1 year
86 800.00158 200.00
3 years
55 000.00158 200.00
5 years
29 700.00158 200.00
10 years
29 700.00158 200.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ki-Seok Kang
CEO | Chief Executive Officer | 48 | 00-01-31 |
Shin-Kyou Kim
CEO | Chief Executive Officer | 59 | - |
Sang-Soo Jung
CHM | Chairman | 66 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shin-Kyou Kim
CEO | Chief Executive Officer | 59 | - |
Sang-Soo Jung
CHM | Chairman | 66 | - |
Ki-Seok Kang
CEO | Chief Executive Officer | 48 | 00-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 0 M€ | +3.22% | - | |
| 0.00% | 0 M€ | +3.45% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 135,800 | +0.67% | 234,584 |
| 24-05-07 | 134,900 | -3.37% | 238,377 |
| 24-05-03 | 139,600 | +8.55% | 410,834 |
| 24-05-02 | 128,600 | +0.78% | 158,062 |
| 24-04-30 | 127,600 | -0.70% | 224,106 |
End-of-day quote Korea S.E., May 07, 2024
More quotes
PharmaResearch Co Ltd, formerly Pharma Research Products Co Ltd, is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The Company mainly provides its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
135,800
KRW
Average target price
175,000
KRW
Spread / Average Target
+28.87%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +24.02% | 1.02B | |
| -3.64% | 88.91B | |
| +4.08% | 41.25B | |
| -15.09% | 31.99B | |
| +53.68% | 24.73B | |
| -15.13% | 15.54B | |
| -8.63% | 12.05B | |
| -40.39% | 12.07B | |
| +6.22% | 8.84B | |
| -5.85% | 8.3B |
- Stock Market
- Equities
- A214450 Stock